N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma

EMBO J. 1991 May;10(5):1119-25. doi: 10.1002/j.1460-2075.1991.tb08052.x.

Abstract

In neuroblastoma, amplification of the N-myc gene is closely correlated with increased metastatic ability. The mechanism by which N-myc acts to increase neuroblastoma malignancy is poorly understood as yet. It is shown here that transfection of N-myc in a neuroblastoma cell line causes suppression of one isoform of protein kinase C, named delta, and induction of an unusual type of protein kinase C, named zeta. N-myc-transfected neuroblastoma cells were found to be blocked in the activation of both c-fos mRNA and the NF-kappa B transcription factor by phorbol ester. Introduction of a protein kinase C expression vector in N-myc transfected neuroblastoma cells restored inducibility of both c-fos and NF-kappa B by phorbol ester. These observations indicate that changes in protein kinase C gene expression significantly alter the response of N-myc-amplified neuroblastomas to a variety of external signals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytosol / metabolism
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • NF-kappa B / genetics
  • Neuroblastoma / genetics*
  • Promoter Regions, Genetic
  • Protein Kinase C / biosynthesis
  • Protein Kinase C / genetics
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-myc / genetics*
  • Signal Transduction / genetics*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transfection
  • Tumor Cells, Cultured

Substances

  • NF-kappa B
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-myc
  • Protein Kinase C
  • Tetradecanoylphorbol Acetate